STOCK TITAN

Rosalind group files Schedule 13G/A reporting stakes in Fennec (FENC)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

FENNEC PHARMACEUTICALS INC. filing amends a Schedule 13G/A to report beneficial ownership stakes by Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon. The filing states ownership percentages of 8.8% (Rosalind Advisors), 8.4% (Rosalind Master Fund), and 8.6% each for Steven Salamon and Gilad Aharon, based on 34,712,756 shares outstanding as of April 13, 2026.

The statement breaks down voting and dispositive powers: the Advisor and the Master Fund hold shared voting and disposition authority over 2,908,201 shares (reported in Item 4), while Mr. Salamon and Mr. Aharon individually report 66,666 shares of sole voting and dispositive power. The filing includes disclaimers from the Advisor and Mr. Salamon regarding beneficial ownership.

Positive

  • None.

Negative

  • None.

Insights

Rosalind group discloses mid‑single‑digit stakes in Fennec.

The filing records beneficial ownership percentages tied to 34,712,756 shares outstanding as of April 13, 2026. It specifies shared voting and dispositive power of 2,908,201 shares for the Advisor/Master Fund and sole voting/dispositive power of 66,666 for each named portfolio manager.

These holdings are presented as disclosed ownership positions; the Advisor and Mr. Salamon include a disclaimer of beneficial ownership. Subsequent filings may clarify any changes to voting arrangements or transfers.

Schedule 13G/A emphasizes shared power and advisor-client structure.

The filing notes the Advisor advises RMF and lists portfolio managers with overlapping authority. The table rows and Item 4 detail shared voting/dispositive powers rather than exclusive control, which is relevant for governance influence assessments.

Watch for any future Form 13D or amendments that would indicate active change in intent or control; this filing presents a passive reporting posture with formal disclaimers in place.

Shares outstanding 34,712,756 shares as of April 13, 2026
Rosalind Advisors shared power 2,908,201 shares shared voting/dispositive power (Item 4)
Rosalind Master Fund shared power 2,908,201 shares shared voting/dispositive power (Item 4)
Steven Salamon sole power 66,666 shares sole voting and sole dispositive power
Gilad Aharon sole power 66,666 shares sole voting and sole dispositive power
Rosalind Advisors percentage 8.8% percent of class reported in Item 4(b)
Rosalind Master Fund percentage 8.4% percent of class reported in Item 4(b)
Salamon / Aharon percentage 8.6% each percent of class reported in Item 4(b)
Schedule 13G/A regulatory
"Amendment No. 2 ) FENNEC PHARMACEUTICALS INC."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned regulatory
"Amount beneficially owned: The information as of the date of the event"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 2,908,201.00"
disclaimer of beneficial ownership regulatory
"the Advisor and Mr. Salamon disclaim beneficial ownership of the shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Rosalind Advisors report in FENC?

Rosalind Advisors reports an ownership percentage of 8.8%. The filing ties that percentage to the issuer's 34,712,756 shares outstanding as of April 13, 2026 and shows shared voting/dispositive authority in Item 4.

How many shares does Rosalind Master Fund L.P. hold in Fennec (FENC)?

Rosalind Master Fund L.P. is reported at 8.4% of the class. Item 4 lists shared voting and dispositive power of 2,908,201 shares associated with the Advisor/Master Fund in the filing.

What voting and dispositive powers do Steven Salamon and Gilad Aharon report?

Each reports 66,666 shares of sole voting and dispositive power and 2,908,201 shares of shared voting/dispositive power. Their combined reported beneficial percentages are each listed as 8.6%.

What baseline share count is used to calculate percentages in the filing?

The filing bases percentages on 34,712,756 ordinary shares outstanding as of April 13, 2026, citing the issuer's DEF14A filing of April 28, 2026 as the source for that outstanding share count.

Does the Advisor claim beneficial ownership of the shares reported?

The filing states the Advisor may be deemed the beneficial owner of shares held by the Master Fund but also records that the Advisor and Mr. Salamon disclaim beneficial ownership. The disclaimer is included verbatim in Item 4(a).





31447P100

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:05/14/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:05/14/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:GIl Aharon
Date:05/14/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:05/14/2026